Day One Biopharmaceuticals Inc (DAWN) — Strategic Asset Allocation Index
Day One Biopharmaceuticals Inc (DAWN) has a Strategic Asset Allocation Index of 1.0% as of September 2025. Strategic assets (PP&E of $4.68 Million plus long-term investments of $-) total $4.68 Million, measured against net assets of $450.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Day One Biopharmaceuticals Inc (DAWN) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Day One Biopharmaceuticals Inc Strategic Asset Allocation Index (2020–2024)
This chart shows how Day One Biopharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the index stands at 1.0%, representing strategic assets of $4.68 Million against net assets of $450.87 Million USD. For live market cap and overall valuation, see how much is Day One Biopharmaceuticals Inc worth.
Annual Strategic Asset Allocation Index for Day One Biopharmaceuticals Inc (2020–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Day One Biopharmaceuticals Inc from 2020 to 2024, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See DAWN book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.9% | $4.71 Million | $4.71 Million | $- | $502.75 Million | ▲ +0.8 pp |
| 2023 | 0.2% | $560.00K | $560.00K | $- | $346.54 Million | ▲ +0.2 pp |
| 2022 | 0.0% | $20.00K | $20.00K | $- | $332.04 Million | ▼ 0.0 pp |
| 2021 | 0.0% | $57.00K | $57.00K | $- | $281.15 Million | ▼ -1.1 pp |
| 2020 | 1.1% | $483.00K | $483.00K | $- | $43.46 Million | — |